Evaluation of hemolysis in patients supported with Impella 5.5: a single center experience
Hemolysis in this high-risk cohort has a poor prognosis. HH patients spent more days on Impella 5.5, needed more MCS, and required more blood product transfusions.
Authors
- Jessica S. Clothier (ORCID: https://orcid.org/0000-0001-9478-3779)
- Raymond Lee
- Jonathan Praeger
- Markian Bojko (ORCID: https://orcid.org/0000-0002-0414-4250)
- Serge Kobsa (ORCID: https://orcid.org/0000-0003-4565-9960)
- Mark L. Barr (ORCID: https://orcid.org/0000-0002-3035-3953)
- Nithya Rajeev (ORCID: https://orcid.org/0000-0001-5632-3739)
- Lynette Lester (ORCID: https://orcid.org/0000-0001-5356-8538)
Institutions
- University of Southern California (US)
Publication Details
- Journal
- Journal of Cardiothoracic Surgery
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1186/s13019-025-03352-7
- Citations
- 1
- Primary Topic
- Mechanical Circulatory Support Devices
- Type
- article
- Field-Weighted Citation Impact
- 0.67